DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2016" report to their offering.
This report provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report covers details of co-promotion and co-marketing agreements from 2010 to 2016.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of all co-promotion and co-marketing deals announced since 2010 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Report Includes:
- Trends in co-promotion and co-marketing dealmaking in the biopharma industry since 2010
- Analysis of co-promotion and co-marketing deal structure
- Case studies of real-life co-promotion and co-marketing deals
- Access to over 700 co-promotion and co-marketing deal records
- Detailed access to actual co-promotion contract documents
Key Topics Covered:
- In-depth understanding of co-promotion and co-marketing deal trends since 2010.
- Analysis of the structure of co-promotion and co-marketing agreements with numerous real life case studies.
- Comprehensive access to over 800 co-promotion and co-marketing deals entered into by the world's biopharma companies, together with contract documents if available.
- Detailed access to actual co-promotion and co-marketing contracts entered into by the leading fifty big pharma and big biotech companies.
- Understand the key deal terms companies have agreed in previous deals.
Report Structure:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in co-promotion and co-marketing dealmaking
Chapter 3 - Overview of co-promotion deal structure
Chapter 4 - Overview of co-marketing deal structure
Chapter 5 - Leading co-promotion and co-marketing deals
Chapter 6 - Top 50 most active co-promotion and co-marketing dealmakers
Chapter 7 - Co-promotion and co-marketing agreement contracts directory 2010- 2016
For more information about this report visit http://www.researchandmarkets.com/research/fnf2j7/global
Related Topics: Biotechnology, Pharmaceuticals, Diagnostics
